Greencross Ltd (ASX: GXL) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Greencross Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Greencross Ltd (ASX: GXL)
Latest News

a woman
Share Market News

Why the National Veterinary Care share price is going nuts today

According to the announcement VetPartners is a privately owned business that already owns 140 veterinary clinics across ANZ and Singapore. 

Read more »

Share Market News

Is this small cap a good ASX growth share?

With today’s news, is National Veterinary Care Ltd (ASX:NVL) an exciting ASX growth option?

Read more »

a woman
Share Market News

Half year report: Why the National Vet Care share price rose 4%

The National Veterinary Care Ltd (ASX:NVL) share price went up 4% after its half year report.

Read more »

Share Market News

5 things to watch on the ASX 200 on Tuesday

Challenger Ltd (ASX:CGF), Insurance Australia Group Ltd (ASX:IAG), and Transurban Group (ASX:TCL) shares will be on watch on Tuesday. Here's…

Read more »

Mergers & Acquisitions

Greencross just declared a special dividend for the remaining shareholders

Greencross Limited (ASX:GXL) just declared a special dividend.

Read more »

a woman
Share Gainers

ALL ORDINARIES finishes higher Thursday: 8 shares you missed

The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Thursday.

Read more »

dog, pet, grooming
Share Market News

Greencross share price rises after receiving court approval for the takeover

The Greencross Limited (ASX:GXL) share price is up after receiving court approval for the takeover.

Read more »

pet, dog, dulux
Share Market News

Is the National Veterinary Care Ltd (ASX:NVL) share price a buy after its AGM?

Is the National Veterinary Care Ltd (ASX:NVL) share price a buy after holding its AGM?

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
12 Feb 2019 $0.1900 100.00% Special Cash 20 Feb 2019
27 Aug 2018 $0.0550 100.00% Final 12 Oct 2018
27 Feb 2018 $0.1000 100.00% Interim 23 Mar 2018
07 Sep 2017 $0.0950 100.00% Final 06 Oct 2017
28 Feb 2017 $0.0950 100.00% Interim 24 Mar 2017
30 Aug 2016 $0.0950 100.00% Final 23 Sep 2016
17 Aug 2015 $0.0900 100.00% 18 Sep 2015
03 Mar 2015 $0.0800 100.00% 31 Mar 2015
04 Sep 2014 $0.0700 100.00% Final 29 Sep 2014
17 Feb 2014 $0.0550 100.00% Interim 14 Mar 2014
06 Sep 2013 $0.0500 100.00% Final 24 Sep 2013
08 Mar 2013 $0.0500 100.00% Interim 22 Mar 2013
27 Aug 2012 $0.0400 100.00% Final 14 Sep 2012
09 Mar 2012 $0.0400 100.00% Interim 30 Mar 2012
22 Aug 2011 $0.0300 100.00% Final 16 Sep 2011
11 Mar 2011 $0.0300 100.00% Interim 29 Apr 2011
05 Oct 2010 $0.0250 100.00% Final 07 Dec 2010
04 Nov 2009 $0.0200 100.00% Final 18 Dec 2009

GXL ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Greencross Ltd

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Stuart Bruce James Non-Executive DirectorNon-Executive Chairman Oct 2009
Mr James has had a career within the Resources, Financial, Healthcare and Pharmaceutical sectors around the world. He had a 25 year career with Royal Dutch Shell Group both in Australia and internationally. His special areas of focus were Retail and South East Asia. He became Managing Director of Australian Financial Services for Colonial and Managing Director of the Colonial State Bank (formerly the State Bank of NSW). Subsequently he became CEO of the Mayne Group with its diverse interests in logistics, healthcare and pharmaceutical, both in Australia and internationally. Following his executive career he has held a number of Non-Executive roles in both Australian and international companies. Between 2006 to 2014 he was a member of the supervisory Board of Wolters Kluwer N.V. He was Chairman of Pulse Health Group - a private hospital operator, Affinity Education Group - a childcare operator, Prime Financial Group - a wealth management and financial advisor business. Stuart was also Chairman of Progen Ltd and NED of Phosphagenics Ltd - both biotech companies. He currently has interests in both fin-tech and healthcare digitisation. His former directorships include Pulse Health Limited, Affinity Education Group Limited, Progen Pharmaceuticals Limited, NED of Phosphagenics Limited.
Dr Glen Frank Richards Non-Executive Director Feb 2014
Dr Richards has over 26 years of experience in the retail and professional services sectors. He was Co-Founder and Director of Mammoth Pet Holdings Pty Ltd, prior to its merger with Greencross Limited in 2014. He established Greencross Vets Pty Ltd in 1994 and PetHQ Pty Ltd in 2005. He has operational experience in fast growing companies, especially in health care and allied health. He established the first western veterinary practice in China (Shanghai PAW) in 2001; was a director of Lyppard Australia, one of Australia's leading veterinary wholesalers. He is currently Chairman of Healthia Ltd (Australia's largest podiatry group), a director of Montserrat Private Day Hospitals (one of Western Australia's and Queensland's largest day hospital groups), Smart Clinics General Medical Practices (with over 35 general practices), Regeneus Ltd (a regenerative medicine company), and 1300Smiles Ltd (a national dentistry group). He continues as a shareholder, advisor and mentor to a number of innovative technology companies (Sourcehub, OneWorld, Smartvet, Clinician Connect and Naturo) that operate nationally and globally in health, retail and agriculture. He holds directorship of 1300 Smiles Limited Regeneus Limited.
Ms Christina (Christy) Boyce Non-Executive Director Sep 2014
Ms Boyce has over 25 years management consulting experience advising major local and international companies in the retail and consumer goods space on marketing and sales strategies. She has worked with a number of major retailers on format renewal, category and pricing strategy and business transformation. She started her career at McKinsey where she co-led the Asia Pacific Retail and Consumer Goods practice. She subsequently acted as a key advisor on a number of major private equity transactions as well as advising on a range of digital transformation projects across a range of industries including retail. She was an advisor and executive at NBN Co during its initial start up with responsibility for regulatory strategy, product and pricing. She continues to provide strategic advice as a director of Port Jackson Partners, a leading consultancy, with a particular focus on strategic direction setting, negotiation strategy and revenue management. She is currently a Non-Executive Director of Monash IVF Group Limited and Oneview Healthcare Plc. Her other directorships include Monash IVF Group Limited. Her former directorships include Cryosite Limited. She is a member of the Risk Management Committee.
Mr Christopher Paul Knoblanche Non-Executive Director Sep 2014
Mr Knoblanche has held a number of high profile leadership (CEO) roles in Australia and across Asia. He sits on a number of boards providing his deep history on governance, financial, accounting and risk management skills. Currently he is the Chair of the Audit and Risk Management Committee for iMed Radiology, Australia's largest provider of radiology and medical diagnostic imaging. During his time in investment banking, he has provided detailed advice in the Australian consumer retail sector. He is currently the Principal of Advisory & Capital Pty Ltd. He previously held the role of Managing Director and Head of CitiGroup Corporate and Investment Banking Australia & New Zealand. He has been CEO of Andersen Australia, CEO of Andersen Business Consulting Asia Pacific and Regional Managing Director of Deloitte Management Solutions - Asia. Prior to CitiGroup, he was a Partner in the boutique Investment bank, Caliburn Partnership (now Greenhill). He serves as Board Member of the Sydney Opera House and the Environmental Protection Authority of NSW. He is Chairman of iSelect Limited. His other directorships include iSelect Limited. He is Chair of the Risk Management Committee.
Mr Paul David Wilson Non-Executive Director Feb 2014
Mr Wilson has over 30 years of experience in the Retail Sector. He co-founded Mammoth Pet Holdings Pty Ltd in 2005. Immediately prior to Mammoth, he held leading edge positions in online commerce and digital marketing: first as Chief Operating Officer of ShopFast and as Managing Director of Adstream Pty Ltd, a leader in the digitalisation of advertising content delivery. During the period, 1987 to 1999 inclusive, he held a number of senior retail positions with Caltex Australia including, National Fuels Pricing and Planning Manager, General Manager of Vitalgas (a Caltex/Boral JV), and as Retail Sales Manager responsible for introducing and growing a competitive retail offer in a network of over 500 Caltex service stations.
Ms Rebekah Horne Non-Executive Director Sep 2015
Ms Horne has had a 20-year career advising many of the world's most respected media brands and is currently the Chief Digital and Data Officer of the NRL. She was previously CDO of Network Ten and CEO of the Los Angeles based start-up, a Google and POLARIS Ventures backed e-commerce business. She has also been responsible for the internationalisation of News Corp's digital business, Fox Interactive Media, starting with the build of the Australian operation, and going on to be the SVP International, responsible for 26 territories outside of the US. Prior to joining News Corp, she held senior positions at SingtelOptus.
Mr Simon Leonard Hickey Chief Executive OfficerManaging Director Mar 2018
Mr Hickey was Group CEO and Managing Director of Campus Living Villages (CLV), the largest global provider of on-campus student accommodation with operations in Australia, New Zealand, the USA and the UK. Prior to joining CLV Mr Hickey was CEO of Qantas International & Freight, responsible for turning around the international business and restructuring the freight operations. Mr Hickey joined Qantas in September 2004 as Group General Manager Strategy and Fleet, and between 2007 and 2012 Mr Hickey was appointed CEO of Qantas Loyalty, responsible for growing the Qantas Frequent Flyer program into Australia's largest coalition program. Mr Hickey began his career with Arthur Andersen as a business consultant working in Sydney, Melbourne and London. Between 2001 and 2004, he was CFO for Bovis Lend Lease Americas. Prior to this, he held various roles with Lend lease including Bovis Lend Lease CFO Asia Pacific.
Mr Vincent Pollaers Company SecretaryGeneral Counsel Apr 2014
Vincent Pollaers Company SecretaryGeneral Counsel

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 33,000,127 27.51%
J P Morgan Nominees Australia Limited 11,561,866 9.64%
Citicorp Nominees Pty Limited 5,173,922 4.31%
Bnp Paribas Nominees Pty Ltd 4,327,139 3.61%
Prebest Pty Limited 3,906,289 3.26%
Willeese Pty Limited 3,099,349 2.58%
James Super Fund Inv Pty Ltd 2,399,704 2.00%
Mr John David Odlum + Mrs Ann Odlum 2,292,408 1.91%
CS Third Nominees Pty Limited 1,984,388 1.65%
Jodav Holdings Pty Ltd 1,921,368 1.60%
Maximum (Nq) Pty Limited 1,896,734 1.58%
Paperbark Pty Ltd 1,473,274 1.23%
National Nominees Limited 1,467,076 1.22%
Bnp Paribas Noms Pty Ltd 1,006,571 0.84%
Michael Alan + Joy Lorraine Hume 618,377 0.52%
Byera Pty Ltd 600,000 0.50%
Citicorp Nominees Pty Limited (i) 541,521 0.45%
Fhhp Pty Ltd 532,935 0.44%
Debuscey Pty Ltd 500,000 0.42%
Navigator Australia Ltd 426,922 0.36%